Explains the history of a controversial and aging breast cancer preventative drug called tamoxifen, the risk assessment processes used to determine whether or not to continue to aggressively market a medication that remains beneficial to some but not all, the risks associated with moral lacunae, and how virtue-imbued casuistry can fortify current risk analysis processes.
Breast Cancer Risk Exposure Androgenic Anabolic Steroid Aging Drug Tamoxifen Citrate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.